Find uplifting stories about heroes, innovations, and solutions
11281 results for "drug addiction prevention"
Salem, Oregon is launching a new initiative to prevent addiction, expand treatment access, and reduce drug trafficking in the community. The city is mapping resources and working with partners to create long-term solutions based on resident feedback.
Weight loss medications like Ozempic and Mounjaro are showing remarkable promise in fighting addiction to all major substances, from alcohol to opioids. A study of over 600,000 veterans reveals these drugs reduce substance use disorders by blocking the cravings that fuel addiction.
New research suggests GLP-1 medications may help treat alcohol, opioid, and drug addictions by quieting cravings in the brain. A study of 600,000 veterans found fewer ER visits and deaths across all substance types.
Popular diabetes and weight loss medications may help fight addiction itself, silencing cravings across alcohol, nicotine, opioids, and other substances. A study of over 600,000 veterans shows these drugs could save lives in unexpected ways.
A groundbreaking VA study found that GLP-1 medications like Ozempic may reduce substance use disorders across alcohol, opioids, nicotine, and other drugs. For veterans battling addiction alongside diabetes, these findings could change everything.
A British pharmaceutical company just completed global patent protection for a groundbreaking addiction treatment. The drug targets brain disorders and is moving closer to clinical trials that could help millions struggling with substance abuse.
A groundbreaking study of 600,000 veterans shows GLP-1 medications like Ozempic dramatically reduce substance use disorders and cut drug-related deaths in half. The discovery could revolutionize how we treat addiction.
Scientists have discovered why drugs like Ozempic reduce cravings for alcohol, nicotine, and other addictive substances. The breakthrough reveals a hidden control center in the brain that manages how we think about rewards.
A massive study of 600,000 veterans found that GLP-1 medications, commonly prescribed for weight loss and diabetes, cut addiction death rates in half. The drugs also reduced the risk of developing substance abuse problems by up to 25% across multiple substances.
A groundbreaking trial found that semaglutide, the popular weight loss drug, significantly reduced alcohol cravings and heavy drinking days in people battling both obesity and alcohol addiction. The discovery could transform treatment options for millions worldwide struggling with alcohol use disorder.
Popular diabetes medications like Ozempic may fight substance addiction by targeting the brain's reward system. A study of 600,000 veterans found users faced lower risks of developing addictions and dying from overdoses.
A Nigerian corps member launched a school campaign against drug abuse that sparked an essay competition, quiz contests, and partnerships promising to expand the initiative nationwide. His story proves national service is about impact, not uniforms.
A medication designed for diabetes is unexpectedly quieting cravings for alcohol, nicotine, and other addictive substances, offering hope where few treatments exist. New research shows it could save thousands of lives each year.
_2026_01_24_00_21_01.jpg)
A father who lost everything to addiction now holds a steady job and is earning back his family's trust. Lisandro Fajardo's story proves recovery is possible, no matter how far you've fallen.
An experimental drug safely activated immune responses against pancreatic cancer in 90% of high-risk patients, offering hope for preventing one of the deadliest cancers. After two years, none of the participants developed cancer.
Scientists are testing the first drug to prevent Ebola infection in people exposed to the deadly Bundibugyo strain. The oral antiviral could protect nearly 1,000 high-risk contacts from developing the disease.
South Africa is partnering with Gilead Sciences to manufacture a revolutionary HIV prevention medicine that requires just two injections per year. The deal could bring affordable access to a drug that offers near-complete protection against HIV infection.
Nigeria will receive a groundbreaking HIV prevention injection that works for six months with just two doses per year, making protection more accessible than ever. The new drug arrives in March 2026 as part of the country's ambitious plan to end the HIV epidemic.
Kenya just received its first shipment of a groundbreaking HIV prevention drug that only requires two injections per year. The game-changing medication will reach high-risk communities starting in March at a fraction of its former cost.
A biotech company is launching with a groundbreaking mission: using GLP-1 medications to treat substance use disorders instead of weight loss. Baseline Therapeutics could open new hope for millions struggling with addiction.
Showing 20 of 11281